Cargando…

Phytosterols and Cardiovascular Disease

PURPOSE OF REVIEW: Coronary heart disease is the leading cause of mortality worldwide. Elevated blood cholesterol levels are not only the major but also the best modifiable cardiovascular risk factor. Lifestyle modifications which include a healthy diet are the cornerstone of lipid-lowering therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Makhmudova, Umidakhon, Schulze, P. Christian, Lütjohann, Dieter, Weingärtner, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410723/
https://www.ncbi.nlm.nih.gov/pubmed/34468867
http://dx.doi.org/10.1007/s11883-021-00964-x
_version_ 1783747160003575808
author Makhmudova, Umidakhon
Schulze, P. Christian
Lütjohann, Dieter
Weingärtner, Oliver
author_facet Makhmudova, Umidakhon
Schulze, P. Christian
Lütjohann, Dieter
Weingärtner, Oliver
author_sort Makhmudova, Umidakhon
collection PubMed
description PURPOSE OF REVIEW: Coronary heart disease is the leading cause of mortality worldwide. Elevated blood cholesterol levels are not only the major but also the best modifiable cardiovascular risk factor. Lifestyle modifications which include a healthy diet are the cornerstone of lipid-lowering therapy. So-called functional foods supplemented with plant sterols lower blood cholesterol levels by about 10–15%. RECENT FINDINGS: In the recent revision of the ESC/EAS dyslipidemia guideline 2019, plant sterols are recommended for the first time as an adjunct to lifestyle modification to lower blood cholesterol levels. However, the German Cardiac Society (DGK) is more critical of food supplementation with plant sterols and calls for randomized controlled trials investigating hard cardiovascular outcomes. An increasing body of evidence suggests that plant sterols per se are atherogenic. SUMMARY: This review discusses this controversy based on findings from in vitro and in vivo studies, clinical trials, and genetic evidence.
format Online
Article
Text
id pubmed-8410723
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-84107232021-09-22 Phytosterols and Cardiovascular Disease Makhmudova, Umidakhon Schulze, P. Christian Lütjohann, Dieter Weingärtner, Oliver Curr Atheroscler Rep Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors) PURPOSE OF REVIEW: Coronary heart disease is the leading cause of mortality worldwide. Elevated blood cholesterol levels are not only the major but also the best modifiable cardiovascular risk factor. Lifestyle modifications which include a healthy diet are the cornerstone of lipid-lowering therapy. So-called functional foods supplemented with plant sterols lower blood cholesterol levels by about 10–15%. RECENT FINDINGS: In the recent revision of the ESC/EAS dyslipidemia guideline 2019, plant sterols are recommended for the first time as an adjunct to lifestyle modification to lower blood cholesterol levels. However, the German Cardiac Society (DGK) is more critical of food supplementation with plant sterols and calls for randomized controlled trials investigating hard cardiovascular outcomes. An increasing body of evidence suggests that plant sterols per se are atherogenic. SUMMARY: This review discusses this controversy based on findings from in vitro and in vivo studies, clinical trials, and genetic evidence. Springer US 2021-09-01 2021 /pmc/articles/PMC8410723/ /pubmed/34468867 http://dx.doi.org/10.1007/s11883-021-00964-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors)
Makhmudova, Umidakhon
Schulze, P. Christian
Lütjohann, Dieter
Weingärtner, Oliver
Phytosterols and Cardiovascular Disease
title Phytosterols and Cardiovascular Disease
title_full Phytosterols and Cardiovascular Disease
title_fullStr Phytosterols and Cardiovascular Disease
title_full_unstemmed Phytosterols and Cardiovascular Disease
title_short Phytosterols and Cardiovascular Disease
title_sort phytosterols and cardiovascular disease
topic Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410723/
https://www.ncbi.nlm.nih.gov/pubmed/34468867
http://dx.doi.org/10.1007/s11883-021-00964-x
work_keys_str_mv AT makhmudovaumidakhon phytosterolsandcardiovasculardisease
AT schulzepchristian phytosterolsandcardiovasculardisease
AT lutjohanndieter phytosterolsandcardiovasculardisease
AT weingartneroliver phytosterolsandcardiovasculardisease